Profile

Cover photo
Dana-Farber/Boston Children's Cancer and Blood Disorders Center
27 followers|6,645 views
AboutPostsPhotosVideos

Stream

 
Children with relapsed or high-risk leukemia have few treatment options. A new Dana-Farber/Boston Children's trial is testing whether DNA sequencing can spot mutations in the cancer cells that can be countered by drugs: http://on.bchil.org/2c8Q02R
1
Add a comment...
 
Many patients rely on shunts to drain excess fluid from their heads. However, the high-tech imaging and surgery needed to check shunts for failure and repair them is tenuous and taxing on the patients. Boston Chidlren’s Dr. Joseph Madsen developed a new device, called ShuntCheck, that can check for shunt failure. Learn more here: http://on.bchil.org/2aQSMx6
Antonio, 14, participated in a study of ShuntCheck, a new device to detect shunt failure.
1
Add a comment...
 
Most children with asthma also have allergies. Could this connection provide clues for asthma prevention? A $20 million, 7-year trial is testing whether the IgE blocker omalizumab (Xolair) in wheezy 2- and 3-year-olds can short-circuit the "allergic march" toward asthma: http://on.bchil.org/2aq5saD
A seven-year randomized, multicenter trial is testing whether omalizumab can prevent asthma in toddlers with wheeze and positive allergy tests.
1
Add a comment...
 
Even after FDA clearance, a handheld device for detecting amblyopia in pediatricians' and school nurses' offices faces an uphill climb. Ophthalmologist-in-Chief David Hunter recaps his journey to date: http://on.bchil.org/2arPgce 
Ophthalmologist David Hunter recounts his journey to bring the Pediatric Vision Scanner through the FDA and to pediatricians for amblyopia screening.
1
Add a comment...
 
In 1964, Gretchen Hall became one of the first children to benefit form corrective congenital heart surgery. Today, she is an inspiration to a growing population of adults who are living with congenital heart disease. Learn more about how Gretchen's optimism, inner strength and knowledge about her condition have helped her over the years: http://on.bchil.org/2ak5jZv 
52 years ago, Gretchen Hall had heart surgery at age 3. Today, she's a living legend and an inspiration to other adults with congenital heart disease.
1
Add a comment...
 
Sirolimus maintains its status as "the new aspirin": It now appears to halt bone loss in Gorham Stout syndrome, a rare vascular anomaly in which lymphatic vessels attack bones in the spine and elsewhere. Learn more here: http://on.bchil.org/2a9lF4v 
In Gorham-Stout syndrome, lymphatic vessels gone amok eat away at bone. Sirolimus, also known as rapamycin, appears to reverse this process.
1
Add a comment...
 
Common business mistakes of scientists, and other insights: Vector sat down with scientist and serial entrepreneur Tim Springer, for his thoughts on bridging academics and the industry. Read more here: http://on.bchil.org/2aJUe0G
Biological chemist, molecular pharmacologist and seven-time entrepreneur Timothy A. Springer, PhD, offers insights for young scientist-innovators.
1
Add a comment...
 
"It’s always fascinating to visit a new country as a team and learn about how the culture, politics, economics and healthcare systems all impact pediatric oncology care." – Irini Albanti, Director at the Global Health Initiative at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. Read this first-hand account of a global oncology conference in Armenia: http://on.bchil.org/2asGzLs
1
Add a comment...
 
Treating children with daytime wetting can be tricky. Carlos Estrada, Jr., MD, director of Boston Children's Voiding Improvement Program, says urinary incontinence is a "complex issue that needs to be pieced together and worked through." Read the Q&A here: http://on.bchil.org/2acNwjT 
1
Add a comment...
 
Teams from more than 40 companies came together at Boston Children’s inaugural Corporate Cup. Read more about how BCH was able to connect with new companies and donors in this Boston Globe feature: http://on.bchil.org/29Z8ylP
1
Add a comment...
 
Amazon's Alexa and Boston Children's innovators are bringing voice technology to health care. What are the unique opportunities here? Take a peek inside our recent brainstorming session: http://on.bchil.org/29Z6Ssi 
Amazon's Alexa and Boston Children's innovators are bringing voice technology to health care. What are the unique opportunities here?
1
Add a comment...
 
Celiac disease is common, but not always recognized by parents and pediatricians. Identifying which children require celiac disease testing is the first step of the evaluation process. Dascha Weir, MD, associate director of Boston Children's Celiac Disease Program, shares a challenging case and her insights on diagnosing, monitoring and reassessing high risk-children. Read more here: http://on.bchil.org/2agTRhd 
"Gluten-free" isn't just another trendy diet for kids with celiac disease. How do you make an official diagnosis, and when should a child go "gluten-free'?
1
Add a comment...
Story
Tagline
Working together for children with cancer – from diagnosis to survivorship
Introduction
The Dana-Farber/Boston Children’s Cancer and Blood Disorders Center provides the combined strengths of two internationally renowned Harvard teaching hospitals. Since the 1940s, when Sidney Farber achieved the first remissions of acute lymphocytic leukemia in children, pioneering physician researchers at Dana-Farber/Boston Children’s have been at the forefront of life-saving breakthroughs in the fight against pediatric cancer and blood disorders. A single team of experts delivers care at a Boston campus connected by pedestrian bridges, with inpatients treated at Boston Children's Hospital and outpatients at Dana-Farber Cancer Institute.
Contact Information
Contact info
Phone
1-855-320-2090
Address
44 Binney Street Boston, MA 02115